Command Palette

Search for a command to run...

coral-laboratories

522.4+2.91%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Deep Value Pick

Coral Laboratories Ltd. stands out as a deep value pick due to its significantly low valuation metrics despite underperformance in growth and profitability compared to its peers. With a PE ratio of just 6.97, it is undervalued relative to its earnings potential, although its financial performance metrics are currently weak.

Key Points
  • Coral Laboratories has the lowest PE ratio among its peers at 6.97, indicating it may be undervalued.
  • It has no debt, giving it a debt-to-equity ratio of 0, which is favorable compared to peers with higher debt levels.
  • Despite its low valuation, Coral's growth metrics show no revenue growth or profitability, indicating challenges ahead.
Top Performers
Mankind Pharma Ltd.

Highest revenue growth YOY at 18.12% and strong profitability metrics.

Dr. Reddy's Laboratories Ltd.

Strong profitability with a PE of 15.50 and high ROE of 21.76%.

Cipla Ltd.

Good growth trajectory with revenue growth of 13.28% YOY and solid profitability.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.